An innovator at heart, Steven Lash holds five business method patents from the U.S. Patent and Trademark Office. He has authored business plans, led leadership retreats, and developed scalable operational models for multi-unit organizations.
Steven Lash is an accomplished business leader, entrepreneur, and strategic advisor with more than 30 years of experience spanning healthcare, finance, capital markets, and emerging ventures. His career is defined by a rare blend of operational acumen and entrepreneurial insight, having held C-suite roles in both established healthcare systems and high-growth startups. Steven Lash’s leadership has consistently driven value through performance turnarounds, business model innovation, strategic planning, and M&A execution.
Steven Lash has served in multiple executive capacities, including President and CEO of DermTech International, where he repositioned the company with a new strategic direction and successfully raised capital. He was previously an investment banker focused on M&A and capital formation, where he advised companies on growth strategies, restructurings, and equity placements. His leadership in these areas reflects his strong financial intellect and ability to identify, scale, and sustain business opportunities.
As Executive Vice President and COO of Sharp Healthcare, Steven Lash was instrumental in transitioning the organization from a single hospital to a vertically integrated health system with its own health plan and offshore insurance captive. He led the creation of a centralized business office covering five hospitals and over 250 physicians, an initiative that drastically improved billing efficiency and financial reporting. As CFO, he spearheaded mergers, acquisitions, and strategic financial planning initiatives that reshaped the healthcare delivery model in Southern California.
Steven Lash’s entrepreneurial influence extends into the venture capital space, serving as a strategic advisor to Assiduity Capital, a Netherlands- and Denver-based fund focused on healthcare innovation in Africa. He has also provided strategic guidance to firms such as Bain Capital and New Harbor Capital, helping portfolio companies scale operations and improve EBITDA performance.
Steven Lash is a boardroom veteran, having served on the boards of IDX (NASDAQ: IDXC), where he helped guide the company to a $1.5 billion acquisition by General Electric, and INC Research, which was sold to Avista Capital Partners at a 12x multiple. Other board roles include Woodward Laboratories and First Dental Health, which was sold to Principal Financial Group for an 8x return. Steven’s expertise in capital strategy, business planning, and integration has been central to these successful exits.
An innovator at heart, Steven Lash holds five business method patents from the U.S. Patent and Trademark Office. He has authored business plans, led leadership retreats, and developed scalable operational models for multi-unit organizations. His thought leadership includes speaking at national conferences and publishing works on reducing employee benefits expense and capital formation in healthcare.
Steven Lash earned his BS in Business from SUNY Binghamton and an MBA from the University of San Diego. His business legacy is marked by transformative growth, visionary leadership, and an unwavering focus on creating value across the healthcare and finance sectors.